2 min read | October 23, 2023
Octiocor Selected for Prestigious KQ Labs Accelerator at the Francis Crick Institute
We’re proud to announce another major milestone in our journey: Octiocor has been selected to join the prestigious KQ Labs accelerator, hosted at the renowned Francis Crick Institute in London. This opportunity places us among an elite group of data-driven health startups working at the forefront of biomedical innovation.
KQ Labs, supported by Health Data Research UK and backed by LifeArc, Innovate UK, and other key ecosystem partners, is one of the UK’s leading accelerators for early-stage companies applying data science to health. Each year, the program selects a small, highly competitive cohort of startups tackling some of the most pressing challenges in healthcare today.
Our selection is a testament to the transformative potential of our AI image analysis software for intracoronary artery imaging, which is designed to support cardiologists with real-time, high-precision diagnostics from catheter-based imaging. Being part of the KQ Labs program also means we’re joining a dynamic community of innovators who, like us, believe in the power of data and AI to transform healthcare. We’re excited to collaborate, learn, and grow alongside fellow startups working on everything from cancer diagnostics to digital therapeutics and beyond.
“Joining KQ Labs is an incredible opportunity to elevate our work and engage with some of the brightest minds in biomedical science,” said Dr Mike Roberts, CTO of Octiocor. “It’s a perfect complement to the support we’ve received from Innovate UK, and it marks a pivotal step as we move closer to commercialising our technology.”
Between the KQ Labs accelerator and the support from our Innovate UK grant, 2024 is shaping up to be a transformative year for Octiocor. We are more committed than ever to advancing precision medicine and delivering cutting-edge diagnostic tools that make a real difference in the lives of patients and the professionals who care for them.
Read next
2 min read | March 19, 2025
AI Image Analysis Co-founders’ Publication Accepted by European Heart Journal Digital Health
In a major step forward for both AI and cardiovascular medicine, the European Heart Journal Digital Health has accepted a comprehensive review by Octiocor Ltd founders Prof. Martin Bennett and Dr. Mike Roberts on the role of artificial intelligence in intracoronary optical coherence tomography (OCT).
Intracoronary OCT is a high-resolution imaging technique that captures detailed views of the coronary arteries, enabling early diagnosis of cardiovascular disease. However, interpreting OCT data remains complex and time-consuming, making it an ideal candidate for AI innovation.
The review examines the current academic publication landscape for AI applications in OCT, spotlighting how machine learning is transforming image analysis, enhancing diagnostic accuracy, and predicting patient outcomes with increasing speed and precision. It also addresses key challenges, including data variability, model generalisability, and regulatory barriers.
“AI holds great potential to dramatically improve diagnostic accuracy in many fields, including cardiovascular imaging,” said Dr. Mike Roberts. “Our review offers a clear snapshot of current capabilities and outlines where we need to go next.”
The publication underscores Octiocor’s leadership at the intersection of AI and cardiovascular imaging—two fields poised for rapid transformation.
“This review is just the beginning,” added Prof. Martin Bennett. “We’re committed to advancing AI tools that can truly make a difference in clinical care.”
Stay tuned for more from Octiocor as they continue to push the boundaries of medical imaging through AI.
1 min read | February 11, 2025
Octiocor’s AutoOCT™ Selected for Oral Presentation at EuroPCR 2025
We’re excited to share that Octiocor’s groundbreaking automated OCT analysis system, AutoOCT™, has been selected for two oral presentations at EuroPCR 2025, Europe’s premier event for interventional cardiovascular medicine, including the prestigious Innovations session. EuroPCR brings together leading experts in cardiology and provides a powerful platform to showcase advancements that could shape the future of cardiovascular care.
The opportunity to present AutoOCT™ at EuroPCR is a significant milestone for Octiocor, as it underscores the growing recognition of our system’s potential to transform the field of cardiac imaging. AutoOCT™ woffers clinicians a faster, more accurate, and repeatable way to analyse OCT images, empowering them to make critical decisions with greater confidence.
We’re looking forward to the engaging discussions and feedback from thought leaders in the cardiovascular community. This recognition is not just a testament to the hard work of our team but also to the incredible promise of AutoOCT™ in improving patient care and advancing the future of interventional cardiology. Stay tuned for more exciting updates as we prepare for this incredible opportunity!
1 min read | October 7, 2024
Octiocor’s AutoOCT™ Shines at 2024 TCT Meeting in Washington D.C.
Octiocor is proud to announce that our cutting-edge automated OCT analysis system, AutoOCT™, was featured in the Innovations session at the prestigious 2024 International Transcatheter Therapeutics (TCT) meeting in Washington D.C. TCT is one of the most influential global forums for interventional cardiology, bringing together experts and innovators from across the world.
During the event, Octiocor co-founder and CMO Prof. Martin Bennett shared insights on the powerful capabilities of AutoOCT™, which will revolutionise the way clinicians analyse optical coherence tomography (OCT) images. As Martin Bennett said ‘We had a great response from both industry and potential funders that we’re currently exploring’, and Octiocor is currently exploring exciting opportunities to advance AutoOCT™ further, thanks to the invaluable connections made at TCT.
At Octiocor, we're committed to improving patient outcomes and advancing medical technology. With AutoOCT™, we’re making significant strides toward providing faster, more accurate diagnostic tools for cardiologists worldwide. Stay tuned for more updates as we continue to innovate and lead the way in cardiac imaging.
3 min read | September 23, 2024
Octiocor Co-founder to Present Pioneering Research on Automated OCT Image Analysis at the Vulnerable Plaque Meeting in Sevilla
We are excited to share another significant milestone for Octiocor! Our cofounder, Professor Martin Bennett, will be presenting cutting-edge research on the automated analysis of OCT (Optical Coherence Tomography) images at the prestigious Vulnerable Plaque Meeting (VPM) in Sevilla, Spain.
About the Presentation
The presentation will highlight the Octiocor team’s innovative work on the development of advanced algorithms for the automated analysis of OCT images, particularly focusing on how these tools can detect vulnerable plaques, potentially life-threatening arterial conditions that can lead to heart attacks.
Through this research, Prof. Bennett and the team at Octiocor have developed a novel approach that enhances the accuracy, speed, and reliability of OCT image analysis. The ability to automatically detect and assess vulnerable plaques could dramatically improve early diagnosis, clinical decision-making, and ultimately patient outcomes. This advancement represents a significant leap in the application of AI and machine learning in medical imaging.
What this Means
The ability to detect vulnerable plaques earlier could revolutionise the way cardiologists and vascular specialists approach cardiovascular disease management. This presentation is particularly timely as the medical community continues to explore more effective methods for identifying at-risk patients, especially when traditional diagnostic methods can sometimes fall short.
At Octiocor, we are driven by our commitment to leveraging technology and research to tackle real-world health challenges. Presenting this work at an esteemed conference like the VPM reinforces our mission to transform healthcare through innovation, while also contributing to the broader academic and medical community.
Looking Ahead: The Future of Automated OCT Image Analysis
As this research evolves, Prof. Bennett and team will continue to lead the way in refining algorithms that integrate artificial intelligence with medical imaging. Our team is working tirelessly to bring these breakthroughs to the clinic, where they can provide tangible benefits to healthcare providers and patients alike.
The insights shared at this event will not only help shape future studies but also strengthen our collaborations with key industry partners. We are excited about the opportunities that lie ahead in medical imaging, and this presentation is a key part of that journey.
Join Us at the Vulnerable Plaque Meeting
If you’re attending the VPM in Sevilla, please message us directly at info@octiocor.com and don’t miss the opportunity to see Prof. Bennett’s presentation in person. We look forward to engaging with experts in the field and discussing how this research can drive progress in diagnosing and treating cardiovascular disease.
Stay tuned for more updates, and thank you for supporting Octiocor as we continue to push the limits of leveraging Artificial Intelligence and Computer Vision in the automated analysis of OCT images.